Jul 25, 2003Type 2 diabetes therapy with insulin (Novolin® human insulin [rDNA origin]) plus metformin provides equivalent blood glucose control but costs two-thirds less than therapy with three oral anti-diabetic agents, study showsNovolin plus metformin treatment also associated with fewer treatment failures and fewer dropouts due to adverse events
Jul 21, 2003Novo Nordisk assures hormone therapy treatments will remain available to patients as license termination negotiations with Pfizer continue
Jun 14, 2003Treatment of diabetic ketoacidosis with insulin aspart injections vs. IV regular insulin avoids ICU care, cutting hospital costs nearly 40 percent, study showsOther study shows people with diabetes prefer combination of insulin aspart and FlexPen® by more than eight-to-one over other rapid-acting insulin and pen delivery device
Jun 14, 2003Study shows insulin detemir results in less variability in blood glucose compared to NPH insulin and insulin glarginePoster no. 518: "Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in subjects with type 1 diabetes"
Visit the download center to download Novo Nordisk video and more
Sign up to receive our new alerts